urea has been researched along with dobutamine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Christ, M; Feuring, M; Georgens, AC; Martin, N; Schmidt, BM; Tillmann, HC; Wehling, M | 1 |
| Azevedo, CH; Bacal, F; Bocchi, EA; Carneiro, RM; Chizzola, PR; Ferreira, SM; Issa, VS; Mangini, S | 1 |
| Cas, LD; Cotter, G; Gheorghiade, M; Metra, M; Sabbah, HN; Teerlink, JR; Zacà, V | 1 |
| Abarzúa, P; Depre, C; Dhar, SK; Malik, FI; Morgans, DJ; Shen, YT; Vatner, SF; Zhao, X | 1 |
| Campia, U; Gheorghiade, M; Nodari, S | 1 |
| Kawashima, S; Kurita, T; Morita, K; Nakajima, Y | 1 |
| Diskin, CJ; Diskin, JB; Oberle, MD; Walker, CB | 1 |
| Anker, SD; Balligand, JL; Bauersachs, J; Brutsaert, D; Carrier, L; Chlopicki, S; Cleland, JG; de Boer, RA; de Keulenaer, G; Dietl, A; Eschenhagen, T; Fischmeister, R; Hamdani, N; Harjola, VP; Heinzel, FR; Heymans, S; Hilfiker-Kleiner, D; Holzmeister, J; Limongelli, G; Linke, WA; Lund, LH; Lyon, AR; Maack, C; Manstein, DJ; Masip, J; Mebazaa, A; Metra, M; Metzger, J; Mueller, C; Papp, Z; Pieske, B; Ponikowski, P; Ristić, A; Ruschitzka, F; Seferović, PM; Skouri, H; Tocchetti, CG; Yilmaz, MB; Zimmermann, WH | 1 |
| Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L | 1 |
| How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L | 1 |
| Hodisch, J; Kadlecová, P; Krumpl, G; Trebs, M; Ulč, I | 1 |
| Hodisch, J; Husch, B; Kadlecová, P; Krumpl, G; Trebs, M; Ulč, I | 1 |
1 review(s) available for urea and dobutamine
| Article | Year |
|---|---|
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
Topics: Acute Disease; Cardiotonic Agents; Digoxin; Dobutamine; Etiocholanolone; Exercise Test; Heart Failure; Hemodynamics; Hospitals, Group Practice; Humans; Hydrazones; Prognosis; Pyrazines; Pyridazines; Quinolines; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Treatment Outcome; Urea; Vasodilator Agents | 2009 |
4 trial(s) available for urea and dobutamine
| Article | Year |
|---|---|
Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Cardiac Output; Creatinine; Cross-Over Studies; Dobutamine; Double-Blind Method; Electrolytes; Heart Rate; Hemodynamics; Humans; Male; Phenylephrine; Placebos; Propanolamines; Renin-Angiotensin System; Urea; Vascular Resistance | 2001 |
Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
Topics: Biomarkers; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Female; Furosemide; Heart Failure; Humans; Hypokalemia; Hyponatremia; Male; Middle Aged; Potassium; Renal Insufficiency; Saline Solution, Hypertonic; Severity of Illness Index; Sodium; Time Factors; Treatment Outcome; Urea | 2007 |
Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiotonic Agents; Cross-Over Studies; Dobutamine; Double-Blind Method; Female; Healthy Volunteers; Heart Rate; Humans; Infusions, Intravenous; Male; Morpholines; Prospective Studies; Urea; Young Adult | 2020 |
Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.
Topics: Blood Pressure; Cross-Over Studies; Dobutamine; Humans; Morpholines; Propanolamines; Prospective Studies; Urea | 2022 |
8 other study(ies) available for urea and dobutamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.
Topics: Analysis of Variance; Animals; Cardiac Myosins; Consciousness; Disease Models, Animal; Dobutamine; Dogs; Drug Administration Schedule; Female; Heart Failure, Systolic; Heart Function Tests; Infusions, Intravenous; Male; Myocardial Contraction; Myocardial Infarction; Oxygen Consumption; Probability; Random Allocation; Stroke Volume; Treatment Outcome; Urea; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?
Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Etiocholanolone; Genetic Therapy; Heart Failure; Humans; Hydrazones; Pyridazines; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Potassium-Exchanging ATPase; Urea | 2010 |
Dobutamine, a β1 Adrenoceptor Agonist, Increases Cerebral Oxygenation During Acute Anemia and Apneic Hypoxia.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Apnea; Cerebrum; Disease Models, Animal; Dobutamine; Hypoxia; Morpholines; Oxygen Consumption; Spectroscopy, Near-Infrared; Swine; Urea | 2017 |
Use of the Fractional Excretion of Urea in an Azotemic Nonoliguric State: Type 1 Cardiorenal Syndrome.
Topics: Aged; Aged, 80 and over; Azotemia; Blood Urea Nitrogen; Cardio-Renal Syndrome; Cardiotonic Agents; Creatinine; Dobutamine; Female; Humans; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Sodium; Survival; Urea | 2018 |
Treatments targeting inotropy.
Topics: Acute Disease; Animals; Antioxidants; Calcium; Cardiotonic Agents; Case-Control Studies; Catecholamines; Clinical Trials as Topic; Diastole; Dobutamine; Dogs; Energy Metabolism; Excitation Contraction Coupling; Heart Failure; Humans; Mitochondria; Models, Animal; Myocardial Contraction; Nitrogen Oxides; Oxidation-Reduction; Phosphodiesterase Inhibitors; Placebos; Receptors, Adrenergic; Sarcomeres; Shock, Cardiogenic; Simendan; Swine; Systole; Urea | 2019 |
Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure.
Topics: Animals; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dobutamine; Drug Therapy, Combination; Heart Failure; Ivabradine; Male; Myocardial Ischemia; Swine; Treatment Outcome; Urea | 2018 |
Combined Therapy With Dobutamine and Omecamtiv Mecarbil in Pigs With Ischemic Acute Heart Failure Is Attributed to the Effect of Dobutamine.
Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Energy Metabolism; Heart Failure; Male; Myocardial Contraction; Myocardial Ischemia; Oxygen Consumption; Sus scrofa; Urea; Ventricular Function, Left | 2020 |